about
Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysemaEpidemiology of chronic obstructive pulmonary disease: a literature review.Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan.Global and regional estimates of COPD prevalence: Systematic review and meta-analysisThe aging lungAssociation Between Average Daily Television Viewing Time and Chronic Obstructive Pulmonary Disease-Related Mortality: Findings From the Japan Collaborative Cohort StudyBurden of obstructive lung disease study in Tehran: Prevalence and risk factors of chronic obstructive pulmonary diseasePrevalence of COPD and tobacco smoking in Tunisia--results from the BOLD studyA multicentre surveillance study on the characteristics, bacterial aetiologies and in vitro antibiotic susceptibilities in patients with acute exacerbations of chronic bronchitis.Prevalence and risk factors of airflow limitation in a Mongolian population in Ulaanbaatar: Cross-sectional studiesThe association between risk of airflow limitation and serum uric acid measured at medical health check-upsDevelopment of a self-scored persistent airflow obstruction screening questionnaire in a general Japanese population: the Hisayama studyContinuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012-2013.Supporting rehabilitation training of COPD patients through multivariate sensor-based monitoring and autonomous control using a Bayesian network: prototype and results of a feasibility study.Surveillance of chronic obstructive pulmonary disease in high-risk individuals by using regional lung cancer mass screening.Life Impact and Treatment Preferences of Individuals with Asthma and Chronic Obstructive Pulmonary Disease: Results from Qualitative Interviews and Focus Groups.Study Design of VESUTO®: Efficacy of Tiotropium/Olodaterol on Lung Hyperinflation, Exercise Capacity, and Physical Activity in Japanese Patients with Chronic Obstructive Pulmonary Disease.Prevalence of chronic obstructive pulmonary disease in kocaeli: an industrialised city in Turkey.Immunological Features of Chronic Obstructive Pulmonary Disease (COPD) Induced by Indoor Pollution and Cigarette SmokeChronic obstructive pulmonary disease and the metabolic syndrome: Consequences of a dual threatCOPD is frequent in conditions of comorbidity in patients treated with various diseases in a university hospital.Suppressed expression of T-box transcription factors is involved in senescence in chronic obstructive pulmonary disease.The efficacy of spirometry as a screening tool in detection of air flow obstructionThe relationship between the COPD Assessment Test score and airflow limitation in Japan in patients aged over 40 years with a smoking history.Spirometric testing on World COPD DayImpact of chronic obstructive pulmonary diseases on left ventricular diastolic function in hospitalized elderly patients.Application of the COOP/WONCA charts to aged patients with chronic obstructive pulmonary disease: a comparison between Japanese and Chinese populations.Questionnaire on switching from the tiotropium HandiHaler to the Respimat inhaler in patients with chronic obstructive pulmonary disease: changes in handling and preferences immediately and several years after the switchPrevalence of chronic obstructive pulmonary disease among smokers attending primary healthcare clinics in Saudi ArabiaAirway inflammation in Japanese COPD patients compared with smoking and nonsmoking controlsRelationships among smoking habits, airflow limitations, and metabolic abnormalities in school workers.Relationships between values of antibodies to several connective tissue disease autoantigens and pulmonary function in a Japanese general population: the Takahata study.A lower level of forced expiratory volume in 1 second is a risk factor for all-cause and cardiovascular mortality in a Japanese population: the Takahata studyClinical pathway for acute exacerbations of chronic obstructive pulmonary disease: method development and five years of experience.Interim Report from Burden of Obstructive Lung Disease (BOLD Study) in Tehran: Prevalence and Risk Factors of Chronic Obstructive Pulmonary DiseaseElectrically stimulated ventilation feedback improves the ventilation pattern in patients with COPD.Impairment of pulmonary function is an independent risk factor for atrial fibrillation: the Takahata study.Novel equations better predict lung age: a retrospective analysis using two cohorts of participants with medical check-up examinations in JapanAnti-inflammatory effects of salmeterol/fluticasone propionate 50/250 mcg combination therapy in Japanese patients with chronic obstructive pulmonary disease.Correlation of a decline in aerobic capacity with development of emphysema in patients with chronic obstructive pulmonary disease: a prospective observational study.
P2860
Q21093297-F0B284BC-D4E8-44FF-8FAC-0548256BDB4BQ22305859-2F7C6A79-B3FF-4C16-99B1-F2312CD7A93BQ24657836-A961A05D-421B-4BF2-97FE-D09E1244286FQ26772278-611A6D5C-8F33-4182-998D-4E65C3709787Q26823383-E2F1A923-0A76-4297-9447-7B684F4B4D64Q28394893-FD0C7C39-AA78-4EB8-AA71-798571F42B6CQ28606967-D1733B63-A067-41EE-BE04-20975D9F0E1DQ28660851-96EDCBDA-C016-4898-9B2E-49B7227312D0Q30998389-218A49F4-59FB-4C95-9D87-DC8CA4516DA9Q33554469-8639DE9C-28B0-4904-8000-E8440DA1764DQ33596469-1B9D0CC8-A81B-4432-A8A6-7951C968F0F4Q33713597-81677E54-D975-4E14-BE5B-18B8D97FD5C0Q33754147-CAE3D811-4A4F-476B-A9BA-2889C3FFB08EQ33763789-A79583F2-C930-4524-894F-F0D9CEFBBBF5Q33821875-73BCEDFA-69C3-4906-93C7-D04C3C6B52D2Q33844382-94598274-8752-4D07-9F52-CEE9314BF33FQ33890852-4122CFDD-66BD-43EB-9024-AA033548685AQ33974119-BD697EFF-34A4-49F5-8CBC-54B75793ADBAQ34126693-9DDD64CD-33E2-4AF9-B21E-E56FE66E2341Q34228984-86D6073E-E29C-490A-95BD-539906339CAAQ34231327-7510B7CC-0C0F-408A-A68A-E24E3EF9200EQ34350843-3124A5A9-B118-41F0-9DFC-19504BC34B02Q34501154-D926D15C-5DB3-4357-BCD1-CB713CE97196Q34700794-5EAEA931-B76C-4CCC-B833-D85FB5E64034Q34721283-9FE323C0-1B39-4A1C-93DC-9091D18BFE20Q34787441-CD1F11CC-6319-4AD4-B141-525A3C2E2464Q34941192-657A6ED3-BA8D-422C-846B-4E6C72C527DBQ34944616-1473CC12-FE67-499D-A645-FC3E3225A9EEQ35008621-326D1F6E-EF86-4CC9-9561-B76FEB35A9A3Q35042664-2F1A1241-54CB-4159-9981-541CFA939751Q35060440-B7F618CC-C690-4BC7-9597-97573AFE6004Q35061281-FC67A341-B275-41BB-B1F3-BBA7B564BB74Q35071075-9CE94AD7-81B6-4A49-8A9C-86DFA7C789CCQ35096992-D9D050FA-6075-4708-B60A-ACC4A440550EQ35112555-6740C01D-23B3-4DC7-80EE-200C1C6B1B02Q35116676-6631509A-7CBD-4F91-A1B8-7D4E3D97BAF4Q35196921-BC2C4AA8-D358-484A-AA51-9376E1E1C372Q35216434-4B8EA1C5-0ABE-4EA7-B5A4-90459CCD6CAEQ35531955-82E5CBCC-1E84-4927-94FB-CB394A47B73EQ35536473-4734BFA9-C143-4233-A70B-31B31940DB89
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
COPD in Japan: the Nippon COPD Epidemiology study.
@ast
COPD in Japan: the Nippon COPD Epidemiology study.
@en
COPD in Japan: the Nippon COPD Epidemiology study.
@nl
type
label
COPD in Japan: the Nippon COPD Epidemiology study.
@ast
COPD in Japan: the Nippon COPD Epidemiology study.
@en
COPD in Japan: the Nippon COPD Epidemiology study.
@nl
prefLabel
COPD in Japan: the Nippon COPD Epidemiology study.
@ast
COPD in Japan: the Nippon COPD Epidemiology study.
@en
COPD in Japan: the Nippon COPD Epidemiology study.
@nl
P2093
P2860
P1433
P1476
COPD in Japan: the Nippon COPD Epidemiology study.
@en
P2093
Atsushi Nagai
Carol Zaher
Hisamichi Aizawa
Keiji Takahashi
Koichi Nishimura
Masaharu Nishimura
Masakazu Ichinose
Mitsuru Adachi
Shinichi Ishioka
Takayuki Kuriyama
P2860
P304
P356
10.1111/J.1440-1843.2004.00637.X
P577
2004-11-01T00:00:00Z